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Abstract
Objectives The purpose of this study was to review the im-
aging features of idiopathic granulomatous mastitis (IGM)
with clinical and pathology correlation.
Methods With institutional review board (IRB) approval, a
retrospective search of the surgical pathology database from
January 2000 to July 2015 was performed. Clinical, imaging
and histology findings were reviewed. Cases of granuloma-
tous mastitis without a known source, diagnosed with percu-
taneous or surgical biopsy, were included in our analysis.
Results Seventeen cases of IGMwere identified with imaging
available for review. The majority of patients presented with a
palpable abnormality, whereas a minority were asymptomatic
with an abnormal screening mammogram. At imaging, IGM
most often demonstrated a focal asymmetry at mammography,
a hypoechoic mass with irregular or angular margins at ultra-
sound, and robust enhancement with mixed progressive and
plateau kinetics at magnetic resonance imaging (MRI).
Axillary lymph nodes were reactive in appearance at ultra-
sound. Molecular breast imaging performed in one case
showed mild focal asymmetric radiotracer uptake.
Conclusion IGM is a rapidly progressive rare inflammatory
condition of the breast resulting in non-necrotizing granuloma
formation. Imaging features mimic breast carcinoma and di-
agnosis can be difficult. Radiologists’ awareness of this con-
dition is essential to prevent delayed or unnecessary treatment.
Teaching points
• Idiopathic granulomatous mastitis is rapidly progressive
inflammatory condition.
• Imaging features may mimic breast carcinoma or infection.
• Ultrasound shows irregular hypoechoic masses with in-
creased vascularity and sinus tracts.
• MRI shows irregular, enhancing masses or non-mass en-
hancement with microabscesses.
• MRI is useful for assessment of breast involvement and re-
sponse to treatment.
Keywords Breast . Granulomatous mastitis . MRI . Breast
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Introduction
Idiopathic granulomatous mastitis (IGM) is a rare, benign in-
flammatory condition of the breast first reported by Kessler and
Wolloch in 1972 [1]. It occurs primarily in women of childbear-
ing age, most often in postpartum or breastfeeding mothers. The
etiology of IGM remains elusive. Reports have suggested an
association with autoimmune disease or the result of a directed
response to trauma, metabolic or hormonal processes [2–5]. An
association with Corynebacterium species has also been pro-
posed [6, 7], though by definition, diagnosis necessitates exclu-
sion of bacteria from microbiology and histology specimens.
Histologically, IGM is characterized by non-necrotizing granu-
loma formation with a localized infiltrate of multi-nucleated
giant cells, plasma cells, epithelioid histiocytes and lymphocytes
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[1, 2, 5, 8–10] (Fig. 1). A neutrophilic infiltrate may also occur
with formation of organized microabscesses [2, 5].
Imaging demonstrates a varied appearance based on the
timing of radiographic evaluation, extent of inflammation
and possibility of prior intervention [4, 8, 11–15]. IGM is
frequently aggressive and typically demonstrates features of
infectious mastitis or inflammatory breast carcinoma.
Diagnosis of IGM can be difficult and is frequently delayed.
Malignancy and all other possible causes of mastitis must be
excluded before a diagnosis of IGM can be considered. Once
diagnosed, treatment is often difficult and prolonged. Current
treatment strategies favor conservative approaches with sur-
gery reserved for refractory or aggressive cases [3, 16–22].
However, recurrence is unpredictable and may result regard-
less of treatment strategy. In this article, we discuss the histo-
pathology, pathogenesis and clinical manifestations of IGM;
provide an imaging update of this rare inflammatory condition
through illustration of cases at mammography, ultrasound,
magnetic resonance imaging (MRI) and molecular breast im-
aging (MBI); and discuss diagnosis, treatment approaches and
outcomes.
Materials and methods
With institutional review board (IRB) approval, a
search of surgical pathology records of approximately
15,500 breast biopsies performed at our institution from
January 2000 to July 2015 yielded 17 cases of IGM
with imaging available for review. Clinical records, im-
aging and pathology specimens were reviewed by sub-
specialists in clinical breast health, breast radiology and
breast pathology. Cases of IGM identified in the study
time frame were diagnosed with image-guided core
needle biopsy or surgical excisional biopsy. All cases
of granulomatous mastitis without an identifiable etiol-
ogy were included in this review; cases of mastitis
attributed to autoimmunity, infection, trauma, metabol-
ic, or hormonal processes were excluded. An additional
case of granulomatous mastitis identified in a 34-year-
old pregnant patient is included as a companion case,
as one of multiple diagnostic/therapeutic breast aspira-
tions grew Corynebacterium kroppenstedtii from the as-
pirated material.
Results
The mean age of IGM diagnosis was 44 years (range 25
to 72). Thirteen patients were premenopausal, all with
prior full term pregnancies. Four patients were postmen-
opausal. The most common clinical presentation was a
new enlarging unilateral breast mass (n = 14) (Fig. 1).
Two patients had either skin ulceration with draining
sinus tracts (Fig. 2) or a raised skin lesion with associ-
ated palpable masses (Fig. 3). Less common complaints
included pain, erythema, nipple discharge, nipple retrac-
tion and axillary fullness. Two patients had skin lesions
seen on the upper extremities consistent with erythema
nodosum (Fig. 1). Four patients were asymptomatic
with an abnormality detected on screening mammogra-
phy. All cases but one were unilateral; bilaterality was
unexpectedly identified at MRI with ill-defined masses
demonstrated in both breasts of a 36-year-old premeno-
pausal patient (Fig. 4).
Fig. 1 A 27-year-old woman with an enlarging palpable right breast
mass admitted to the hospital for intractable joint pain. An erythematous
rash was noted on her right breast and extremities. She was 8 months
post-partum, breastfeeding with difficulty on the right. Bilateral
mediolateral oblique mammogram (a) demonstrates regional asymmetry
in the middle depth upper breast (arrows). b Clinical photograph of the
patient’s forearm shows erythematous areas (arrows), representing
erythema nodosum. c Photomicrograph (original magnification ×200;
haematoxylin-eosin [H-E] stain) showing non-necrotizing granulomatous
inflammation (arrow) composed of histiocytes and giant cells
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Mammography was available in 16 cases. IGM pre-
sented mammographically as unilateral focal or regional
asymmetry in 12 patients (Fig. 1). There was associated
architectural distortion and irregular mass in four cases.
Interestingly, one case presented at screening mammog-
raphy with segmental coarse heterogeneous calcifica-
tions (Fig. 5). Mammography failed to identify an ab-
normality in four patients (24 %), presumably due to
overlapping dense breast parenchyma obscuring poten-
tial findings.
Ultrasound (n = 15) demonstrated a hypoechoic
mass(es) with indistinct, irregular or angular margins,
hyperechoic rim and internal vascularity (Figs. 2, 3, 4
and 6). Posterior acoustic shadowing was noted in four
cases (Fig. 4). Sonographically reactive appearing nodes
were identified in the ipsilateral axilla of eight patients.
Fine needle aspiration of axillary lymph nodes in three
cases showed similar results: mixed lymphocytic popu-
la t ion consis tent wi th a reac t ive lymph node.
Hypoechoic sinus tracts were noted to interleave be-
tween otherwise normal parenchyma, extending between
masses or to the skin in seven cases (Fig. 2).
MRI (n= 5) demonstrated irregular enhancing masses,
most with ill-defined margins and surrounding non-mass
enhancement. Mixed progressive and plateau enhance-
ment kinetics were observed in all cases (Figs. 2, 4
and 6), some interspersed with small regions of more
rapid contrast enhancement and washout. Three ad-
vanced cases demonstrated T2 hyperintense, peripheral-
ly enhancing masses with central areas of non-
enhancement representing abscess formation (Fig. 2).
Enlargement of the affected breast with skin and nipple
involvement was identified in one case (Fig. 4).
Restricted diffusion (b = 0, b = 800) was also noted in
regions of involvement (Fig. 4) with mean ADC values
of 1.0 × 10−3mm2/s (adjacent normal parenchyma
2.3 × 10−3mm2/s). Axillary lymphadenopathy was not a
prominent feature at MRI with reactive changes noted
in the axillary nodes.
MBI performed in one patient with unilateral breast
pain demonstrated mild unilateral nonmass subareolar
uptake corresponding to nonmass ductal enhancement
noted on comparison MRI examination (Fig. 7).
Seven patients were treated with observation only,
one had her oestrogen stopped, three were treated with
prednisone and antibiotics, and one with repeated per-
cutaneous drainage. Five patients proceeded to surgical
excision following failure of conservative measures.
Long-term follow-up was available in eight patients
ranging from 1 to 12 years (mean 4 years). There were
three patients with recurrences at 1, 5 and 7 years re-
spectively. The first patient demonstrated clinical reso-
lution initially but had recurrence of symptoms at 1 year,
Fig. 2 A 24-year-old Albanian mother of a 4-year-old (breastfed for
1 year) presented with a left breast lump, pain, erythema and drainage
from multiple sites. Clinical photograph (a) of the left breast shows four
eschars (arrows), two of which in the upper breast were draining cloudy
fluid. Also shown is nipple inversion. b Ultrasound (US) image of the
upper left breast shows a hypoechoic mass with indistinct margins with
tract extending into adjacent tissue and to the skin surface (arrows) to the
uppermost eschars noted the clinical photograph (a). cAxial T1-weighted
post-contrast subtraction axial MRI image shows an irregular, intensely
enhancing mass in the left breast extending to the chest wall with central
areas of non-enhancement consistent with abscess formation. Ultrasound
biopsy revealed IGM
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which resolved following surgical excision of the affect-
ed area. The second patient recurred 5 years following
surgical excision. She was treated with observation
alone, with resolution of symptoms within 6 months.
The third patient was initially treated with surgical ex-
cision with a recurrence in the same breast 7 years later.
She was subsequently treated with anti-inflammatories
only and was then lost to follow-up.
Discussion
IGM is a diagnosis of exclusion requiring careful his-
topathology review of biopsy specimens, as well as
microbiological analysis. This rare inflammatory pro-
cess is characterized by non-necrotizing granuloma for-
mation in breast lobules (Fig. 1c). Necrosis is rare, a
finding more typically seen with tuberculous mastitis
[2, 10, 23, 24]. An associated inflammatory infiltrate
composed of multi-nucleated giant cells, plasma cells,
epithelioid histiocytes, and lymphocytes are typically
isolated within affected lobules [4, 5, 10, 23]
(Fig. 1c). Depending upon severity, this inflammatory
response may extend into adjacent breast lobules.
Involved parenchyma demonstrates loss of acinar struc-
ture and damaged ducts [2, 24]. A neutrophilic infil-
trate and formation of sterile microabscesses may also
be demonstrated [2, 19, 23].
The precise etiology of IGM is uncertain. Current
theories of IGM etiology favor an inflammatory re-
sponse within the connective tissue of breast stroma to
glandular secretions leaked from damaged ductal epithe-
lium [2]. Inflammation is localized within lobules and
may result in a chemical mastitis. Potential precipitating
factors include autoimmune disease, pregnancy and
lactation, hyperprolactinemia, oral contraceptive use,
trauma, and foreign body reaction, among others.
The autoimmune hypothesis is supported by the ob-
servation that some patients with IGM demonstrate
extramammary manifestations of autoimmune disease
such as inflammatory arthritis and erythema nodosum,
exhibit a T-lymphocyte rich inflammatory infiltrate, and
often respond favorably to treatment with corticoste-
roids [2, 8, 18, 25, 26] (Fig. 1). However, serological
tests that are routinely positive in patients with auto-
immune disease, such as rheumatoid factor (RF) and
anti-nuclear antibody (ANA), demonstrate variable pos-
itivity in patients with IGM [8]. The association of
pregnancy and lactation stems from the observation
that the majority of women afflicted with IGM are
premenopausal, as well as parous, and are either preg-
nant at the time of diagnosis or have given birth within
5 years of experiencing symptoms [23]. Nevertheless,
postmenopausal patients have also been diagnosed with
this condition, as seen in our series. Elevated prolactin
levels (endogenous or exogenous source) as a potential
trigger of IGM [5] is supported by the hypothesis that
hyperprolactinemia may contribute to increased ductal
secretions, leading to damaged ductal epithelium. An
association with trauma has also been suggested [23],
though difficult to substantiate. Interestingly, the major-
ity of patients diagnosed with IGM are from develop-
ing countries. While this observation might reflect un-
derdiagnosis of tuberculous mastitis [21], further inves-
tigation into the geographic disparity of this aggressive
inflammatory disorder may be helpful towards elucida-
tion of an etiology.
Microorganisms must be absent from histopathology
specimens and aspirates of affected tissue, including pre-
sumed abscess cavities. Gram stain, culture, and special
stains including Zehl-Neelsen, Periodic acid-Schiff, GMS
Fig. 3 A 50-year-old woman presenting with painful, rapidly enlarging
areolar skin lesion and breast mass. Clinical photograph (a) of the left
breast shows a raised red skin lesion at the 9 o’clock position of the areola.
Skin biopsy showed non-necrotizing granulomatous inflammation. b US
image of the left areola and nipple show a hyperechoic area of skin
thickening, which involves the dermis but does not connect to the
underlying breast tissue. c US of the palpable breast mass demonstrates
an irregular hypoechoic mass with angular margins and hyperechoic rim
which did not connect to the areolar skin lesion. Percutaneous biopsy
showed non-necrotizing granulomatous inflammation. Special stains for
microorganisms were negative
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or other silver staining methods must be negative.
Nevertheless, there have been a few reports of
Corynebacterium species associated with tissue and fluid
obtained from patients with presumed IGM [6, 7]. One
pregnant patient from our series with clinical and imag-
ing findings typical of granulomatous mastitis grew
Corynebacterium kroppenstedtii from one of many other-
wise sterile aspirations from her left breast. Importantly,
her ultrasound findings were identical to cases of IGM
from our study cohort, showing irregular hypoechoic
masses with angular margins, communicating sinus
tracts, and marked vascularity of the breast parenchyma
on color Doppler evaluation (Fig. 8).
Symptoms in patients with IGM can include a palpa-
ble lump, localized or regional erythema, focal tender-
ness and peau d’orange [23, 27]. Nipple involvement is
infrequent, but can include discharge [4, 12], scaling and
retraction, with or without pain. Unilateral symptoms are
most often reported; involvement of both breasts is less
common [8]. The majority of patients are female, al-
though cases have also been identified in males [10,
23, 28]. Most patients are premenopausal and report
Fig. 4 A 36-year-old female mother of two with a left breast lump and
bilateral breast pain; IGM affecting both breasts. This patient breastfed both
children; the last time was 2 years prior to presentation. a Bilateral
mediolateral oblique mammograms show heterogeneously dense breast tis-
sue but no abnormality in the left upper breast in the region of the palpable
mass. bUS image of the left upper outer breast shows a mixed echogenicity
shadowing mass with indistinct margins (arrows), corresponding to a region
of patient concern. cAxial T1 weighted post-contrast MIP with color kinetic
analysis demonstrates bilateral heterogeneous enhancement, left greater than
right, showing extent of involvement in both breasts (blue represents pro-
gressive enhancement and green plateau enhancement). d Sagittal diffusion-
weighted (b=800) image (left), corresponding ADCmap (centre; 0.9×10−3
mm2/s), and time intensity enhancement curve (right) of the right breast
demonstrates moderate restricted water diffusion with lower mean ADC
values than what is observed in normal breast tissue
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childbirth and breastfeeding within the previous 5 years;
however, cases of IGM have been identified in patients
as young as 11 and as old as 80 [27]. Occasionally,
unilateral axillary lymphadenopathy is detectable on
physical examination [22], a finding concerning for
breast carcinoma with nodal metastatic disease. Eschars,
ulceration and draining sinus tracts have been reported
(Fig. 2). In some cases, sinus tracts may develop at the
location of percutaneous core needle biopsy [8], presum-
ably due to inadequate healing at the biopsy site. In
advanced disease, the involved breast can be significant-
ly enlarged and demonstrate skin retraction in more than
one quadrant.
Mammographic findings in IGM include focal or re-
gional asymmetry, a solitary mass or masses, skin thick-
ening, skin and nipple retraction and axillary lymphade-
nopathy [4, 8, 11–15, 29]. In our series, the most com-
mon mammographic finding was a moderate-sized focal
asymmetry corresponding to a region of palpable con-
cern (Fig. 1). Regional asymmetry, trabecular thickening
or multifocal involvement may also be noted in the af-
fected breast. Skin thickening may occur, particularly
when findings are noted in the anterior depth tissue.
Nevertheless, mammography can also be normal, partic-
ularly in patients with dense breasts and/or a mild in-
flammatory response (Fig. 4). In many cases, the affect-
ed breast may appear larger than the contralateral breast,
a finding most apparent on the full field mediolateral
oblique view. Calcifications are exceedingly rare, but
have been reported [4] in IGM (Fig. 5). Importantly,
the mammographic appearance of IGM can be indistin-
guishable from invasive or inflammatory breast cancer
prompting further imaging evaluation.
Ultrasound is helpful for evaluation of palpable abnor-
malities in patients with a normal mammogram (Fig. 4).
Fig. 5 A 37-year-old asymptomatic mother of three who finished
breastfeeding her third child 4 months prior to scheduled screening mam-
mogram. a Unilateral right mediolateral oblique and b magnified
craniocaudal mammograms demonstrate abundant segmental coarse hetero-
geneous calcifications not present on a prior comparison study performed
2 years earlier (not shown). c Photomicrograph (original magnifica-
tion× 100; H-E stain) of stereotactic biopsy specimen demonstrates calcifi-
cations (arrows) in the background of histiocytic inflammation within a
breast lobule
Fig. 6 A 39-year-old woman treated with multiple prior incision and
drainages of the lateral lower left breast, presenting with new pain and
palpable thickening left inner upper breast. a Post-contrast, vibrant, T1-
weighted, fat-saturated axial MRI image showing extensive rapid
enhancement of the left inner breast with central areas of non-
enhancement consistent with microabscess formation. b US of the same
area shows multiple serpiginous hypoechoic areas with increased vascu-
larity noted on color Doppler evaluation
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Sonographic findings in IGM are variable and can include
masses, architectural distortion, parenchymal edema, fluid
collections, skin thickening and axillary lymphadenopa-
thy [4, 8, 11–15, 29, 30]. The most common ultrasound
findings are of a mixed echogenicity but predominantly
hypoechoic mass with angular, irregular or indistinct mar-
gins, with or without sinus tracts insinuating into adjacent
parenchyma (Figs. 2,4 and 6). There are variable degrees
of posterior acoustic phenomena, including both enhance-
ment and shadowing [8, 11, 31] (Fig. 4). Doppler imaging
demonstrates increased internal blood flow within lesions
and the surrounding breast parenchyma (Figs. 6 and 8) [4,
29]. In advanced cases, disease may present as fluid col-
lections or abscess cavities, which can be aspirated for
microbiological analysis [8]. Ultrasound is useful for doc-
umentation of sinus tracts extending to the skin surface, a
finding that can be seen with delay in diagnosis or history
of prior intervention (Fig. 2) [8, 12, 15]. Ultrasound is
also helpful in evaluation of enlarged axillary lymph
nodes, which most often demonstrate smooth reactive
cortical thickening.
MR is a useful adjunct to mammography and ultra-
sound in evaluation of patients with IGM, indicated in
patients with advanced, aggressive, or refractory disease.
Importantly, MR provides the best estimate of disease
extent and contralateral breast involvement. MRI findings
in IGM are variable depending upon the severity of in-
flammation. Heterogeneous ill-defined masses and non-
mass enhancement with mixed kinetics were identified
in our series, as was noted in previously reported cases
[8, 29–31] (Figs. 2 and 4). Often, progressive or plateau
enhancement patterns predominate with interspersed areas
of rapid enhancement and washout. Irrespective of kinet-
ics, the affected parenchyma demonstrates intense en-
hancement compared to uninvolved tissue (Fig. 2).
There may be associated peripherally enhancing masses
with increased internal T2 signal , represent ing
microabscesses [8]. In advanced disease, larger fluid col-
lections can be seen interspersed within abnormal en-
hancement, with or without sinus tracts extending to the
skin surface [8] (Figs. 2 and 6). Involved parenchyma
displays restricted diffusion in the majority of cases
(Fig. 4) with consistently lower mean ADC values
(1.0 × 10−3mm2/s) than what is observed for normal breast
parenchyma (2.3 × 10−3mm2/s). Our mean ADC values for
IGM are close to those identified for suspicious breast
lesions [32] and similar to what is reported for granulo-
matous inflammation of the prostate [33]. Presumably, the
chronic inflammatory response in IGM results in reduced
water diffusion capacity and decreased relative ADC
values. Importantly, although ADC values in IGM are
falsely positive for malignancy, time intensity curves are
more benign, consistent with inflammation. Skin
Fig. 7 A 50-year-old woman with right breast pain and redness not resolv-
ing with antibiotics. Biopsy showed IGM. a Dual head prototype MLO
bilateral molecular breast imaging (MBI) scanned prior to commercially
availableMBI demonstratesmild unilateral right non-mass subareolar uptake
(arrows) best seen on the superior detector (upper left image). The posterior
area of mass enhancement (arrowhead) was a biopsy proven fibroadenoma.
Left breast is negative. b Axial T1 weighted post gadolinium fat saturated
MRI image shows non-mass enhancement in the right subareolar region
corresponding to the focal uptake on MBI (arrows); MR-guided biopsy
revealed IGM. The enhancing fibroadenoma is noted posterior depth right
breast (arrowhead)
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thickening is well demonstrated, as is rare involvement of
the nipple and nipple areolar complex. Importantly, MR
allows for assessment of disease progression or regression
over time, potentially useful in difficult cases treated with
conservative therapy or for documentation of recurrence.
Our solitary case with MBI demonstrated low-level
nonmass uptake corresponding to mild nonmass enhancement
identified on the comparison MRI (Fig. 7). Given the findings
in our series, and additional evidence supporting the use of
MBI to identify mammographically occult breast carcinoma,
MBI would likely prove highly sensitive for detection of in-
flammatory uptake expected from IGM [34].
Because IGMmimics bacterial mastitis, commonly seen in
young breastfeeding patients, early treatment with antibiotics
is often employed, without success, leading to further workup.
Surgical therapy, using wide local excision or mastectomy
depending on extent of disease, was the treatment of choice
in the 1970s and 1980s [21, 35, 36]. However, recurrence rates
are high with surgery—approaching 25%—particularly when
excision of actively inflamed tissue is performed, often
resulting in multiple re-operations to achieve cure [22, 37].
Recurrence may also be delayed, requiring additional treat-
ment months after initial therapy. A hybrid approach has also
been utilized with surgical excision performed after sufficient
delay to allow for reduction in the degree of acute inflamma-
tion within the breast [12]. Conservative management has
gained popularity in the last 20 years and is currently the
preferred approach, with treatment options including close
clinical surveillance, corticosteroid therapy, or treatment with
direct immunomodulators such as methotrexate. Importantly,
published reports using corticosteroids and immunomodula-
tors for therapy include small sample sizes and there is cur-
rently no clinical consensus that these medications perform
better than watchful waiting.
Conclusion
IGM is a rare inflammatory condition of the breast that mimics
infectious mastitis or inflammatory breast carcinoma. Clinical
diagnosis is often one of exclusion, is delayed in the majority
of cases, but should be facilitated by imaging. Contemporary
breast imaging techniques are essential in documenting dis-
ease extent, providing guidance during percutaneous core nee-
dle biopsy and in helping to exclude malignancy. MR imaging
can be useful in monitoring IGM behavior and clinical im-
provement, particularly in patients managed conservatively.
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